Cogent Biosciences (COGT) Leases (2019 - 2021)
Historic Leases for Cogent Biosciences (COGT) over the last 3 years, with Q3 2021 value amounting to $3.2 million.
- Cogent Biosciences' Leases fell 3561.24% to $3.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.2 million, marking a year-over-year decrease of 3561.24%. This contributed to the annual value of $4.6 million for FY2020, which is 1267.74% down from last year.
- Latest data reveals that Cogent Biosciences reported Leases of $3.2 million as of Q3 2021, which was down 3561.24% from $3.7 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Leases ranged from a high of $6.3 million in Q1 2019 and a low of $3.2 million during Q3 2021
- Over the past 3 years, Cogent Biosciences' median Leases value was $4.9 million (recorded in 2020), while the average stood at $4.9 million.
- Per our database at Business Quant, Cogent Biosciences' Leases plummeted by 1043.66% in 2020 and then tumbled by 3561.24% in 2021.
- Over the past 3 years, Cogent Biosciences' Leases (Quarter) stood at $5.3 million in 2019, then dropped by 12.68% to $4.6 million in 2020, then fell by 29.6% to $3.2 million in 2021.
- Its Leases was $3.2 million in Q3 2021, compared to $3.7 million in Q2 2021 and $4.2 million in Q1 2021.